Topic

Articles

The industry wide shift to decentralized clinical trials includes considerations for sponsors and CROs such as global availability, global technology, and data integration. 

Harness Technology to Scale Global Hybrid Decentralized Studies

Bayesian methods bring flexibility and speed to clinical trial design and analysis, and with increased access to the necessary computational power, are transforming today’s clinical research.

Employing the Power of Bayesian Methods to Expedite Learning

Both quality personnel and the FDA have predicted some of the issues with pandemic operations, but much is still unknown on the impact these rapidly implemented pandemic processes.

Clinical Trial Quality Concerns Arise Amidst COVID

Randomized controlled trials establish strict inclusion and exclusion criteria in an effort to optimize the cohort of trial participants.

Real-World Evidence Studies can Enhance Diversity and Equity in Clinical Research

Findings from a Tufts study examining the effects of COVID-19 on clinical trials.

COVID-19 and Its Impact on the Future of Clinical Trial Execution

Tips for reducing site queries and improving workflows.

Better Cardiac Safety Trials

With the assistance of mobile research nursing, in-home visits provide solid alternative to trial participants, especially during COVID-19.

When Trials Stumble, Mobile Research Nursing Lends a Helping Hand

Decentralized clinical trials (DCTs) have ignited clinical transformation while the COVID-19 pandemic has fueled their rapid expansion.

Five Tips to Help Research Sites Implement Decentralized Clinical Trials

ACT's Editor-in-Chief, Lisa Henderson, assesses the sustainability of remote trials.

The Future of Remote Trials

Jody Casey of Elligo Health Research gives insight into the issue of diversity in trials and what needs to be done to correct it.

Trial Design